Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Pasquale De Franciscis, Antonio Schiattarella, Gaetano Riemma, Domenico Labriola, Domenico Ambrosio, Salvatore Giovanni Vitale, Antonio Cianci, Gaspare Cucinella, Gloria Calagna & Nicola Colacurci. (2022) Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study. Minimally Invasive Therapy & Allied Technologies 31:3, pages 435-440.
Read now
Read now
Simona Del Forno, Eugenia Degli Esposti, Paolo Salucci, Deborah Leonardi, Raffaella Iodice, Alessandro Arena, Diego Raimondo, Roberto Paradisi & Renato Seracchioli. (2020) Liver function, tolerability and satisfaction during treatment with ulipristal acetate in women with fibroids: a single center experience. Gynecological Endocrinology 36:5, pages 445-447.
Read now
Read now
Natalie Woodhead, Rachel Pounds, Shirin Irani & Poonam Pradhan. (2018) Ulipristal acetate for uterine fibroids: 2 years of real world experience in a UK hospital. Journal of Obstetrics and Gynaecology 38:6, pages 813-817.
Read now
Read now
Articles from other publishers (2)
O.A. Melkozerova & A.V. Murzin. (2022) New visualization technologies in operative gynecology: strategies and prospects. Rossiiskii vestnik akushera-ginekologa 22:1, pages 52.
Crossref
Crossref
Laudine Communal, Myriam Vilasco, Justine Hugon-Rodin, Aurélie Courtin, Najat Mourra, Najiba Lahlou, Morwenna Le Guillou, Muriel Perrault de Jotemps, Marie-Pierre Chauvet, Marc Chaouat, Pascal Pujol, Jean Feunteun, Suzette Delaloge, Patricia Forgez & Anne Gompel. (2016)
Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with
BRCA1
mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited
BRCA1
mutations
. Oncotarget 7:29, pages 45317-45330.
Crossref
Crossref